NCT02980679View on ClinicalTrials.gov

A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Thyroid Gland Diseases
Interventions
DRUG

CTC

After injection of CTC, a whole body and thyroid scan will be performed.

DRUG

G-PERT

After injection of G-PERT, a whole body and thyroid scan will be performed.

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02980679 - A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery | Biotech Hunter | Biotech Hunter